Cyto-111

N/A

Report date: 2025/03/19 11:14:20

Base Information

Drug NameCyto-111

Drug Alias NameCyto-111B8C1adB8-BoNT/C1 ad

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragment > Single-domain antibody (Nanobody)

Mechanisms of ActionBotulinum toxin inhibitors

TargetsBotulinum toxin

Therapy Area/IndicationsBotulism

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesCytoDel Inc

China Registration ClassN/A

Develop Information

Active CompaniesCytoDel Inc

Inactive CompaniesN/A

Active IndicationsBotulism

Inactive IndicationsN/A

Other Information

ATC CodeN/A